Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3336 of 6351
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis phase I trial investigates the side effects and best dose of talazoparib when given together with trifluridine/tipiracil for the treatment of patients with colorectal or gastroesophageal cancer that has spread to nearby tissue or lymph nodes (locally advanced) or other place…
Phase 1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Immunotherapy duo tackles rare nerve cancer in early trial
Disease control CompletedThe purpose of the study is to evaluate safety and feasibility of neoadjuvant nivolumab plus ipilimumab prior to standard therapy (surgery, chemotherapy or radiation therapy) in patients with Neurofibromatosis Type 1 (NF1) and newly diagnosed pre-malignant and malignant periphera…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThe investigators have recently demonstrated the strong impact in terms of survivals of Fms-like tyrosine kinase 3 ligand (FL) levels evaluated during intensive induction in acute myeloid leukemia (AML) patients. Indeed, three FL kinetic profiles were delineated: i) sustained inc…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Money stress and suicide: new study tests peer coaching to save lives
Knowledge-focused PausedFinancial hardship is an important risk factor for suicide. However, there are no evidence-based interventions to help individuals at risk for suicide to improve their financial situation. The intervention will support participants to address their financial difficulties (e.g., i…
Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New drug cocktail shows promise in shrinking breast tumors before surgery
Disease control CompletedThis phase I trial tests the side effects and best dose of abemaciclib and niraparib in treating patients with breast cancer that is positive for estrogen or progesterone receptors (hormone receptor positive \[HR+\]) and HER2 negative. Abemaciclib may stop the growth of tumor cel…
Phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Exercise shows promise for easing PTSD in older veterans
Symptom relief CompletedPosttraumatic stress disorder (PTSD) is prevalent among military Veterans and is more than just a psychological condition; PTSD has profound negative impacts on health, function, and quality of life. Older Veterans are the largest patient population served by the Veterans Health …
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
Knowledge-focused OngoingThe purpose of this this study, to evaluate the quality of sexual life of patients treated for anal cancer treated by radiotherapy, during their treatment, then 3 months after treatment and, finally, 2 years after treatment. cancer diagnosis.
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New anal insert aims to stop leakage and improve lives
Symptom relief CompletedThe purpose of this study is to assess the cost-effectiveness and improvement in quality of life of using a novel anal insert (navina)
Sponsor: Maastricht University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New hope for kidney transplant patients: safer rejection prevention?
Disease control Stopped earlyThe purpose of this study is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of escalating doses of TCD601 when compared to rATG in de novo renal transplant patients.
Phase 2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Heart health may predict lung cancer treatment success
Knowledge-focused OngoingThis study aimed to investigate the role of impedance cardiography (ICG) in evaluating hemodynamic changes during the 6-minute walk test (6MWT) in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who underwent combined concurrent chemoradiotherapy (CCRT) and i…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New brain valve aims to ease fluid buildup
Disease control Recruiting nowThe SAPPHYRE study is an ambispective (retrospective and prospective) PMCF study with the objective to evaluate the safety and performance of the Polaris® 24 adjustable valve system in the treatment of 126 patients with hydrocephalus.
Sponsor: Sophysa • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cool cap could keep Kids' hair safe during chemo
Symptom relief Recruiting nowThis study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditions or solid tumors. Primary Objective * To assess the safety and feasibility of the use of a scalp cooling device in p…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a natural compound in fruits help heart surgery recovery?
Disease control CompletedThe purpose of this study is to test the anti-inflammatory and anti-senescence effects of quercetin during coronary artery by-pass graft surgery.
Phase 2 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Bladder cancer trial halted: could trilaciclib have saved bone marrow?
Disease control Stopped earlyThis is a Phase 2, multicenter, randomized, open-label study evaluating the safety and efficacy of trilaciclib administered with platinum-based chemotherapy followed by trilaciclib administered with avelumab maintenance therapy compared with platinum-based chemotherapy followed b…
Phase 2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Therapy tailored for south asian canadians shows promise for mental health
Symptom relief CompletedAs CBT was developed for persons from North America and European background it needs to be adapted for persons from non-Western cultures. This mixed methods study proposes a culturally adapted Cognitive Behavioural Therapy (CA-CBT) model for Canadians of South Asian origin. Begin…
Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Paramedics at your door: new program fights dangerous low blood sugar
Disease control PausedThis pilot study will assess the feasibility, preliminary efficacy, and acceptability of the Diabetes-REM (Rescue, Engagement, and Management), a comprehensive patient-centered intervention delivered by community paramedics in the community setting to improve diabetes self-manage…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a Plant-Based diet stop a blood cancer before it starts?
Prevention OngoingThis study will test whether a plant-based diet is practical (feasible) for overweight people with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). The researchers will decide how practical the diet is by looking at how much weight p…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 26, 2026 15:05 UTC
-
Could a day hospital visit ease chronic pain?
Symptom relief CompletedChronic Regional Pain Syndrome (CRPS) is a chronic disabling disease. Patients present a variable picture associating pain localized to an articular or peri-articular region, motor and vasomotor disorders and trophic disorders. Its pathophysiology, still poorly understood to thi…
Sponsor: Centre Hospitalier le Mans • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New MRI technique could sharpen MS diagnosis
Diagnosis CompletedPatients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which four additional 20-minute sequences will be added. MRI of routine care in the context of MS includes at least the following sequences: * 3D T1 TFE (2 minutes) *…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Placenta extract shows promise for liver disease in early trial
Disease control CompletedPart A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.
Phase 2 • Sponsor: Green Cross Wellbeing • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC